What is the share price of Swiss Parenterals Ltd?

Company share prices are keep on changing according to the market conditions. The current trading price of Swiss Parenterals Ltd on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Swiss Parenterals?

The latest standalone P/E ratio of Swiss Parenterals as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Swiss Parenterals Ltd?

The latest standalone P/B ratio of Swiss Parenterals Ltd as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Swiss Parenterals Ltd?

The 52-week high of Swiss Parenterals Ltd is Rs. 0.00 and the 52-week low is Rs. 0.00.

Swiss Parenterals Ltd Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Swiss Parenterals Ltd
Brand: Swiss Parenterals

Swiss Parenterals Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Swiss Parenterals Share Price

Swiss Parenterals Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Swiss Parenterals Share Price

Key Metrics

Valuation Multiples

Market Cap

₹0 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹8.8

TTM Sales

₹56.7 Cr.

Book Value per Share

₹45.6

P/E Ratio

0.00

Industry PE

46.5

Price to Book (P/B)

0.00

Price to Sales (P/S)

0.00

EV/EBITDA

0.00

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

37.69%

Return on Capital Employed (ROCE)

48.99%

Return on Assets (ROA)

23.32%

Operating Profit Margin

30.8%

Net Profit Margin

23.55%

Gross Profit Margin

33.5%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

24.13%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

40.86%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

21.73%

Asset Quality

Promoter Holding

99.99%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹26 Cr.

Equity

₹7.4 Cr.

Face Value

₹10

All Time Low / High

- / -

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	21.4%	18.6%	9.3%	16.1%	27.4%	57.8%	42.4%	49%	-
Growth Parameters ⓘ
Sales ⓘ	40.7	47	48.4	48.3	56.7	223	291	362	57
Sales YoY Gr.	-	15.7%	2.8%	-0.1%	17.4%	293.9%	30.4%	24.1%	-
Adj EPS ⓘ	8	6.1	1.2	3.3	8.7	75.4	104	151.3	8.8
YoY Gr.	-	-23.9%	-80.7%	180.3%	164.3%	769.1%	38%	45.5%	-
BVPS (₹) ⓘ	26.3	31.9	33.1	0	44.9	369.1	328.6	481	45.6
Adj Net Profit ⓘ	3.8	3.4	0.7	2.4	6.4	55.6	58	84.5	6
Cash Flow from Ops. ⓘ	2.8	7.7	3.9	6.1	3.6	14.5	107	91	-
Debt/CF from Ops. ⓘ	6.5	1.9	4.5	0	4.2	0.7	0.2	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	49.5%	85.5%	24.1%
Adj EPS ⓘ	NA	164.5%	159.4%	45.5%
BVPSⓘ	NA	70.8%	120.4%	46.4%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	28.6	21.8	3.6	10.6	21.1	36.3	25.5	37.4	3.3
Op. Profit Mgn % ⓘ	17.3	15.1	14	17.9	24.5	34.7	27.5	30.8	NAN
Net Profit Mgn % ⓘ	9.3	7.2	1.4	5	11.3	24.9	19.9	23.4	11.4
Debt to Equity ⓘ	1.6	0.8	1	0	0.5	0	0.1	0	-
Working Cap Days ⓘ	0	162	181	96	99	182	226	251	0
Cash Conv. Cycle ⓘ	0	15	45	52	54	44	57	57	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'23	Mar'24	Mar'25
Sales	40.66	47.03	48.35	48.29	56.69	223.32	291.29	361.58
Operating Expenses ⓘ +	33.65	40.12	41.59	39.64	42.82	145.82	212.24	250.23
Manufacturing Costs	9.18	10.94	11.85	9.84	13.55	15.11	30.57	24.48
Material Costs	19.51	23.41	22.31	20.54	19.24	92.56	116	162.01
Employee Cost	1.29	2.13	2.81	2.98	3.96	9.66	24.57	24.24
Other Costs ⓘ	3.67	3.63	4.61	6.28	6.07	28.49	41.10	39.50
Operating Profit ⓘ	7.01	6.91	6.76	8.65	13.87	77.50	79.05	111.35
Operating Profit Margin (%)	17.2%	14.7%	14.0%	17.9%	24.5%	34.7%	27.1%	30.8%
Other Income ⓘ +	0.21	0.34	0.33	0.68	0.71	11.87	27.54	10.18
Exceptional Items ⓘ	-0.16	-0.15	0	-0	-0	0	0	0
Interest ⓘ	0.70	1.11	2.07	1.69	1.19	0.98	0.24	0.22
Depreciation ⓘ	0.60	1.27	3.92	3.58	3.11	7.79	3.59	5.62
Profit Before Tax ⓘ	5.77	4.72	1.11	4.06	10.28	80.59	102.76	115.69
Tax ⓘ	2.04	1.58	0.39	1.43	3.81	21.50	32.82	30.55
Profit After Tax	3.72	3.15	0.72	2.63	6.46	59.09	69.94	85.14
PAT Margin (%)	9.2%	6.7%	1.5%	5.4%	11.4%	26.5%	24.0%	23.6%
Adjusted EPS (₹)	7.8	5.7	1.3	0.0	8.8	80.2	125.3	152.6
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Swiss Parenterals - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	12.47	17.77	18.45	27.07	33.59	272.08	183.42	268.37
Share Capital ⓘ	1.06	1.24	1.24	1.64	7.37	7.37	5.58	5.58
Reserves ⓘ	11.42	16.53	17.21	25.43	26.21	264.71	177.84	262.79
Debt +	16.19	14.79	17.47	8.21	15.37	9.96	20.01	1.36
Long Term Debt	12.54	10.38	11.29	5.89	6.15	0	0	0
Short Term Debt	3.65	4.41	6.18	2.32	9.22	9.96	20.01	1.36
Minority Interest	0	0	0	0	0	0	0	0
Trade Payables	9.42	10.83	11.94	8.83	10.59	15.66	34.85	42.48
Others Liabilities ⓘ	9.22	4.07	11.13	6.01	8.03	41.79	87.41	92.37
Total Liabilities ⓘ	47.31	47.46	58.98	50.12	67.57	339.49	325.69	404.58
Fixed Assets
Net Fixed Assets ⓘ +	5.18	25.37	23.86	20.89	18.92	46.78	59.11	62.95
Gross Block	9.16	30.48	32.94	33.52	34.47	54.66	70.53	79.42
Accumulated Depreciation	3.98	5.11	9.08	12.63	15.54	7.88	11.42	16.47
CWIP ⓘ	14.85	0.26	0.18	0	4.21	1.81	0.21	11.71
Investments ⓘ	0	0	0	0	0	25.38	5	5
Inventories	11.03	7.74	9.95	7.49	8.76	23.21	36.17	28.95
Trade Receivables	6.43	6.35	14.98	9.91	19.09	49.27	81.13	89.03
Cash Equivalents	2.33	1.94	4.21	4.89	7.13	79.20	66.36	22.90
Others Assets ⓘ	7.49	5.80	5.80	6.94	9.46	113.84	77.71	184.04
Total Assets ⓘ	47.31	47.46	58.98	50.12	67.57	339.49	325.69	404.58

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	2.83	7.68	3.90	6.10	3.63	14.48	107.12	91.02
PBT ⓘ	5.77	4.72	1.11	4.06	10.28	80.59	102.76	115.69
Adjustment ⓘ	1.23	2.32	5.98	4.99	4.02	1.86	-19.02	0.01
Changes in Working Capital ⓘ	-2.12	1.74	-2.43	-1.22	-6.61	-43.87	54.65	-3.14
Tax Paid ⓘ	-2.06	-1.10	-0.76	-1.73	-4.06	-24.11	-31.27	-21.54
Cash Flow From Investing Activity ⓘ +	-12.43	-6.93	-2.24	-0.48	-7.37	-9.19	32.13	-68.51
Capex	-13.10	-6.87	-2.39	-0.74	-5.01	-2.57	-14.31	-22.41
Net Investments	0	0	0	0	0	-12.83	36.93	47.91
Others ⓘ	0.67	-0.06	0.15	0.27	-2.36	6.22	9.51	-94.01
Cash Flow From Financing Activity ⓘ +	10.74	-1.15	0.61	-4.95	5.97	10.07	-148.87	-19.04
Net Proceeds from Shares ⓘ	1.44	1.36	0	6	0	0	0	0
Net Proceeds from Borrowing ⓘ	8.74	-2.16	0.91	-5.40	0.27	0	0	0
Interest Paid ⓘ	-0.70	-1.11	-2.07	-1.69	-1.19	-0.22	-0.24	-0.15
Dividend Paid ⓘ	0	0	0	0	0	0	-55.82	0
Others ⓘ	1.26	0.75	1.77	-3.86	6.90	10.29	-92.81	-18.89
Net Cash Flow ⓘ	1.14	-0.39	2.27	0.68	2.23	15.37	-9.62	3.47

Financial Ratio

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	33.17	21.71	3.99	11.54	21.48	43.44	30.71	37.69
ROCE (%)	21.38	18.55	9.26	16.1	27.36	57.84	42.43	48.99
Asset Turnover Ratio	0.88	1.04	0.96	0.92	1.02	1.32	0.88	0.99
PAT to CFO Conversion(x)	0.76	2.44	5.42	2.32	0.56	0.25	1.53	1.07
Working Capital Days
Receivable Days	56.10	47.40	76.20	90.40	88.50	80.50	81.70	85.80
Inventory Days	96.30	69.60	63.20	63.30	49.60	37.90	37.20	32.80
Payable Days	176.30	157.90	186.30	184.50	184.20	30.90	79.50	87.10

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Swiss Parenterals Ltd FAQs

The current trading price of Swiss Parenterals on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Swiss Parenterals stood at ₹0.00 Cr

The latest P/E ratio of Swiss Parenterals as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Swiss Parenterals as of 31-Dec-1969 is 0.00.

The 52-week high of Swiss Parenterals is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Swiss Parenterals is ₹56.69 ( Cr.) .

Data is not available for this company.

No data found

About Swiss Parenterals Ltd

No data to display

Swiss Parenterals Ltd

Swiss Parenterals Ltd

10 Year X-Ray :